Cargando…
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
Obesity is a global epidemic that is a leading cause of preventable death. In addition to lifestyle modification, there are numerous obesity treatments for clinicians to consider, including medications. Lorcaserin immediate release/extended release (IR/XR) is a US Food and Drug Administration approv...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130259/ https://www.ncbi.nlm.nih.gov/pubmed/30233224 http://dx.doi.org/10.2147/DMSO.S126855 |